• CEO Expenses - Q1
  

• ‎CEO Expenses - Q1
• CEO Expenses - Q2
  
• CEO Expenses - Q3
  
• CEO Expenses - Q4
  
• Statement of Executive Compensation
  
• PHSA Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  

Financial Statements for the year ended March 31, 2023

Reports for the year ended March 31, 2022

• CEO Expenses - Q1
  
• CEO Expenses - Q2
  
• CEO Expenses - Q3
  
• CEO Expenses - Q4
  
• Statement of Executive Compensation
  
• PHSA Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  
• Employee remuneration greater than $75,000 (PHSA)
  
• Supplier payments greater than $25,000 (PHSA)
  

Reports for the year ended March 31, 2021

• CEO Expenses - Q1
  

• CEO Expenses - Q2
  

• CEO Expenses - Q3‎
  

• CEO Expenses - Q4 (B. Morin)
  

• CEO Expenses - Q4 (D. Byres)

• Statement of Executive Compensation
  

• PHSA Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  
• Employee remuneration greater than $75,000 (PHSA)
  
• Supplier payments exceeding $25,000 (PHSA)
  

‎Financial Statements for the year ended March 31, 2021

• PHSA Consolidated
  
• Forensic Psychiatric Services Commission
  
• BC Emergency Health Services
  

Financial statements for the year ended March 31, 2020

• PHSA Consolidated
  

• Forensic Psychiatric Services Commission
  

• BC Emergency Health Services 
  

Reports for the year ended March 31, 2020

• CEO Expense Report
  

• PHSA Board Remuneration
  

• Forensic Psychiatric Services Commission Board Remuneration
  

• BC Emergency Health Services Board Remuneration
  

• Statement of Executive Compensation
  

• Employee remuneration greater than $75,000 (PHSA)
  

• Supplier payments exceeding $25,000 (PHSA)
  

Financial statements for the year ended March 31, 2019

• PHSA Consolidated
  
• Forensic Psychiatric Services Commission
  
• BC Emergency Health Services
  

Reports for the year ended March 31, 2019

• CEO Expense Report‎
  
• PHSA Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• BCCSS Board Remuneration
  
• Statement of Executive Compensation
  
• Employee remuneration greater than $75,000 (PHSA)
  
• Supplier payments exceeding $25,000 (PHSA)
  

Financial statements for the year ended March 31, 2018

Reports for the year ended March 31, 2018

• CEO Expense Report
  
• Statement of Executive Compensation
  
• PHSA Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• Employee remuneration greater than $75,000 (PHSA)
  
• Supplier payments exceeding $25,000 (PHSA)

Financial statements for the year ended March 31, 2017

• PHSA Consolidated
  
• BC Cancer
  
• BC Centre for Disease Control
  
• Children's and Women's Health Centre of BC
  
• BC Transplant
  
• BC Mental Health and Substance Use Services
• Forensic Psychiatric Services Commission
  
• BC Emergency Health Services
  

Reports for the year ended March 31, 2017

• CEO Expense Report
• Statement of Executive Compensation
  
• PHSA Board Remuneration
  
• BC Emergency Health Services Board Remuneration
  
• Forensic Psychiatric Services Commission Board Remuneration
  
• Employee remuneration greater than $75,000
  
• Supplier payments exceeding $25,000
  

Financial statements for the year ended March 31, 2016

• PHSA Consolidated
  
• BC Cancer
• BC Centre for Disease Control
• Children's and Women's Health Centre of British Columbia
• BC Transplant
• BC Mental Health and Substance Use Services
• BC Emergency Health Services
• Forensic Psychiatric Services Commission

Other reports for the year ended March 31, 2016

• CEO Expense Report
  
• PHSA Board Remuneration 
  
• BC Emergency Health Services Board Remuneration 
  
• Forensic Psychiatric Services Commission Remuneration 
  
• Statement of Executive Compensation
• Employee remuneration greater than $75,000
• Supplier payments greater than $75,000